| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,461 |
7,236 |
$772K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,210 |
6,067 |
$435K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,598 |
1,515 |
$214K |
| G0378 |
Hospital observation service, per hour |
224 |
212 |
$199K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
489 |
476 |
$80K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,282 |
10,965 |
$56K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
241 |
240 |
$51K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
561 |
548 |
$49K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
498 |
488 |
$40K |
| 80051 |
|
7,596 |
7,314 |
$38K |
| 82565 |
|
7,910 |
7,459 |
$36K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,573 |
3,328 |
$34K |
| 70450 |
Computed tomography, head or brain; without contrast material |
617 |
601 |
$31K |
| T1015 |
Clinic visit/encounter, all-inclusive |
858 |
244 |
$29K |
| 84520 |
|
7,417 |
7,165 |
$29K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
132 |
130 |
$27K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
164 |
161 |
$25K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
315 |
315 |
$25K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,596 |
1,535 |
$24K |
| 80076 |
|
2,961 |
2,765 |
$21K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
527 |
455 |
$19K |
| 82947 |
|
7,213 |
6,836 |
$18K |
| 80053 |
Comprehensive metabolic panel |
1,883 |
1,686 |
$16K |
| 0002A |
|
396 |
393 |
$16K |
| 0001A |
|
411 |
410 |
$15K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
425 |
409 |
$15K |
| 80050 |
General health panel |
316 |
308 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
603 |
589 |
$15K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
438 |
425 |
$14K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
93 |
93 |
$14K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
208 |
204 |
$14K |
| 71250 |
|
202 |
201 |
$13K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
374 |
163 |
$11K |
| 80061 |
Lipid panel |
919 |
897 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,614 |
1,293 |
$11K |
| 71045 |
Radiologic examination, chest; single view |
1,784 |
1,693 |
$11K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
41 |
41 |
$11K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
36 |
36 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,747 |
2,581 |
$11K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
238 |
238 |
$10K |
| 76830 |
Ultrasound, transvaginal |
234 |
234 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,547 |
1,365 |
$10K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
165 |
159 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
664 |
652 |
$9K |
| 84484 |
|
1,241 |
1,092 |
$8K |
| 83880 |
|
325 |
313 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,110 |
1,051 |
$7K |
| 93975 |
|
125 |
123 |
$7K |
| 83690 |
|
1,730 |
1,606 |
$7K |
| 81001 |
|
2,777 |
2,633 |
$7K |
| 76801 |
|
169 |
151 |
$7K |
| 77066 |
Tomosynthesis, mammo |
78 |
78 |
$7K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
314 |
314 |
$7K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
141 |
137 |
$6K |
| 83735 |
|
1,064 |
901 |
$6K |
| 93971 |
|
123 |
116 |
$5K |
| 85730 |
|
964 |
918 |
$5K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
26 |
26 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,050 |
866 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
143 |
129 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
148 |
147 |
$4K |
| 82607 |
|
396 |
383 |
$4K |
| 85610 |
|
1,442 |
1,320 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
696 |
687 |
$4K |
| 73610 |
|
200 |
193 |
$4K |
| 84439 |
|
528 |
514 |
$4K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
34 |
18 |
$4K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
14 |
14 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
87 |
86 |
$3K |
| 84702 |
|
229 |
206 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
182 |
182 |
$3K |
| 85379 |
|
342 |
337 |
$3K |
| 81025 |
|
844 |
813 |
$3K |
| 73562 |
|
187 |
172 |
$3K |
| 77065 |
Tomosynthesis, mammo |
42 |
40 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
56 |
55 |
$3K |
| 82803 |
|
135 |
127 |
$3K |
| 83605 |
|
471 |
412 |
$3K |
| 76642 |
|
63 |
63 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
377 |
371 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
30 |
29 |
$2K |
| 73630 |
|
210 |
189 |
$2K |
| 85027 |
|
432 |
369 |
$2K |
| 72141 |
|
12 |
12 |
$2K |
| 82728 |
|
216 |
208 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
30 |
29 |
$2K |
| 86850 |
|
333 |
321 |
$2K |
| 76536 |
|
41 |
38 |
$2K |
| 70496 |
|
13 |
13 |
$2K |
| 88342 |
|
245 |
243 |
$2K |
| 87186 |
|
297 |
282 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
598 |
417 |
$2K |
| 70498 |
|
12 |
12 |
$2K |
| 83721 |
|
198 |
192 |
$1K |
| 72100 |
|
65 |
65 |
$1K |
| 84481 |
|
61 |
60 |
$1K |
| 73030 |
|
90 |
85 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
148 |
146 |
$1K |
| 86803 |
|
86 |
82 |
$1K |
| 86901 |
|
360 |
334 |
$1K |
| 86900 |
|
362 |
335 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
4,728 |
3,647 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
334 |
220 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
31 |
31 |
$1K |
| 82550 |
|
222 |
210 |
$1K |
| 87088 |
|
196 |
181 |
$1K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
13 |
$1K |
| 87040 |
|
109 |
66 |
$1K |
| 82746 |
|
125 |
121 |
$1K |
| 82043 |
|
140 |
134 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
144 |
101 |
$991.10 |
| 96367 |
|
41 |
13 |
$983.03 |
| 93970 |
|
14 |
13 |
$982.12 |
| 59025 |
Fetal non-stress test |
110 |
73 |
$825.33 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
21 |
15 |
$815.93 |
| 83550 |
|
182 |
176 |
$768.46 |
| 93017 |
|
31 |
31 |
$762.63 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$761.90 |
| 84132 |
|
187 |
173 |
$760.74 |
| 73620 |
|
87 |
85 |
$756.23 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
32 |
12 |
$754.41 |
| 0004A |
|
16 |
16 |
$710.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
28 |
26 |
$672.69 |
| 82330 |
|
163 |
153 |
$662.73 |
| 86140 |
|
265 |
239 |
$633.94 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
28 |
26 |
$629.63 |
| 84295 |
|
156 |
144 |
$626.29 |
| 82310 |
|
378 |
367 |
$541.71 |
| 82948 |
|
768 |
455 |
$516.70 |
| 85014 |
|
291 |
262 |
$501.40 |
| 73110 |
|
41 |
40 |
$464.08 |
| 85652 |
|
176 |
160 |
$461.58 |
| 87806 |
|
15 |
14 |
$432.60 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13 |
13 |
$424.08 |
| 82435 |
|
115 |
109 |
$381.38 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
650 |
392 |
$373.67 |
| 36591 |
|
75 |
47 |
$358.50 |
| 73130 |
|
29 |
29 |
$349.07 |
| 86038 |
|
26 |
25 |
$347.25 |
| 84153 |
|
14 |
14 |
$335.84 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
49 |
44 |
$328.81 |
| 85007 |
|
99 |
85 |
$314.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
226 |
175 |
$300.19 |
| 94060 |
|
26 |
26 |
$290.27 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,659 |
1,446 |
$260.70 |
| 86618 |
|
12 |
12 |
$260.09 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$243.56 |
| 87070 |
|
51 |
43 |
$225.65 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,432 |
2,007 |
$162.71 |
| 87205 |
|
55 |
43 |
$161.79 |
| 84100 |
|
27 |
17 |
$159.56 |
| 87077 |
|
29 |
28 |
$144.17 |
| 83615 |
|
29 |
26 |
$133.03 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
68 |
48 |
$112.64 |
| 96376 |
|
299 |
160 |
$99.08 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
904 |
624 |
$86.38 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
890 |
691 |
$77.42 |
| 87147 |
|
25 |
16 |
$69.45 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
64 |
62 |
$69.06 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
99 |
67 |
$43.72 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
17 |
16 |
$29.53 |
| 97162 |
|
12 |
12 |
$29.13 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
995 |
820 |
$23.15 |
| 85018 |
|
14 |
12 |
$17.92 |
| J2704 |
Injection, propofol, 10 mg |
2,512 |
2,143 |
$16.56 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
89 |
80 |
$13.89 |
| 88304 |
|
17 |
13 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
19 |
16 |
$0.00 |
| 76000 |
|
12 |
12 |
$0.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
41 |
27 |
$0.00 |